Clin2
NCT07239973Likely a fitRecruiting

Study of BGM0504 Tablets for overweight or obese adults

HealthyNon-diabetic Overweight or Obese

Treatments studied

Part of Hormones & metabolism clinical trials.

This trial tests a new tablet, BGM0504, in healthy adults who are overweight or obese but do not have diabetes. It aims to see how the medicine works and if it is safe for this group.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
75 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You are overweight or obese with a body mass index (BMI) of 24.0 or higher, or you are a healthy volunteer with a BMI between 20.0 and 28.0.
  • Your weight has stayed stable (within 5%) for the last 3 months.
  • You are willing to use effective birth control if you or your partner could become pregnant.
  • You have no serious health conditions or allergies to the study drug ingredients.
  • You can attend all study visits and follow the study rules.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07166081Recruiting· Phase 1
Study of BGM0504 tablets in overweight or obese adults

This study tests an investigational tablet called BGM0504 for weight management in adults with overweight or obesity but without diabetes. It looks at how the drug works in your body and how safe it is over time.

Baltimore, Maryland
NCT07725809Not yet recruiting· Phase 1
Study of a new medicine for adults with overweight or obesity

This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.

Brussels, Bruxelles-capitale, Région de
NCT07294235Recruiting· Phase 1
Study of BGM1812 injection for healthy and overweight or obese participants

This trial tests an investigational drug called BGM1812 given as an injection. It is for healthy Chinese adults who are either at a normal weight or are overweight/obese but not diabetic. The study will see how the drug works in the body and check for side effects.

Kunming, Yunnan
NCT07658560Not yet recruiting· Phase 2
Testing BGM0504 tablets for weight loss in non-diabetic adults

This trial tests BGM0504 tablets for weight loss in overweight or obese Chinese adults who do not have diabetes. It checks if the pills are safe and effective for helping you lose weight when paired with diet and exercise.

Beijing, Beijing Municipality
NCT07566572Recruiting· Phase 1
Safety Study of BGM0504 Tablets in Healthy Chinese Adults

This is an early-stage safety study testing a new tablet called BGM0504 in healthy volunteers. Researchers want to understand how the body handles this drug and check for any side effects.

Hangzhou, Zhejiang
NCT07784699Not yet recruiting· Phase 1
Study of an oral drug for healthy and overweight adults

This trial tests a new oral medication (GZC8072) in two groups: healthy people given a single dose, and people who are overweight or obese given multiple doses. The study aims to see if the drug is safe and how the body handles it, and may help with weight management.

Beijing

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.